We use in situ reflection high-energy electron diffraction to investigate the growth kinetics of cubic (001)-GaN/GaAs grown by plasma-assisted molecular beam epitaxy. We find that the GaN surface exhibits three surface reconstructions having (1×1), (2×2), and c(2×2) symmetries, which correspond to Ga adatom coverages of 0, 0.5, and 1, respectively. We demonstrate that the transient behavior of the half-order streak intensity is a sensitive probe of the surface stoichiometry during growth. Particularly, these measurements enable us to directly determine the effective N flux incorporated into the crystal.
GaAs (001) surfaces in both metalorganic vapour phase epitaxy (MOVPE) and molecular beam epitaxy (MBE) are studied under As stabilisation as well as during growth by reflectance anisotropy spectroscopy (RAS). During MBE growth reflection high energy electron diffraction (RHEED) measurements are performed simultaneously. As a consequence of the oscillating density of steps during island growth, time resolved RAS measurements show oscillations with monolayer periodicity in both epitaxial systems. In order to separate morphology related and surface reconstruction domain related contributions to RAS oscillations an anisotropic effective medium model is applied. In both MBE and MOVPE domains of reduced As coverage close to the island boundaries are found to be responsible for RAS oscillations. In MBE this typically results in oscillations between spectra belonging to (2 x 4) reconstructions of different mean As dimer density. In MOVPE the surface oscillates between states with an increased and a decreased concentration of G a dimers while c(4 x 4)-like As dimers are still present.') Hardenbergstr.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.